Skip to main content

sodium nitroprusside

Generic: SODIUM NITROPRUSSIDE·Brand: NIPRIDE, NIPRIDE RTU IN SODIUM CHLORIDE 0.9%, NITROPRESS, Nipride, SODIUM NITROPRUSSIDE

sodium nitroprusside: developed by 2 companies · 2 FDA decisions.

sodium nitroprusside evidence translation

What we can confirm

2 FDA records

What it means

More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

What is verified about sodium nitroprusside, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Development Pipeline (3)
CompanyPhase
NEXUS BIOPHARMA INC (NEXS)Approved
NEXUS BIOPHARMA INC (NEXS)Approved
DR REDDYS LABORATORIES LTD (RDY)Approved
FDA Decisions2 records
ApprovalINDICATIONS AND USAGE Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside injection can be minimized. Sodium nitroprusside is also indicated for producing controlled hypotension in order to reduce bleeding during surgery. Sodium nitroprusside is also indicated for the treatment (RDY)FDA ↗
ANDA210114UNKNOWNStandardOtherInjectable
Approval(NEXS)FDA ↗
ANDA207499UNKNOWNStandardOtherInjectable

Frequently asked questions

Who is developing sodium nitroprusside?

sodium nitroprusside is being developed by NEXUS BIOPHARMA INC, DR REDDYS LABORATORIES LTD.

What is sodium nitroprusside's latest FDA decision?

The most recent tracked FDA decision for sodium nitroprusside is Approval for INDICATIONS AND USAGE Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside injection can be minimized. Sodium nitroprusside is also indicated for producing controlled hypotension in order to reduce bleeding during surgery. Sodium nitroprusside is also indicated for the treatment , dated April 10, 2019.